VIVE News and Press, Viveve Medical Inc. From 03/18/21

Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intim...

ENGLEWOOD, CO / ACCESSWIRE / March 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the virtual H.C. Wainwright Global Life Sciences Conference, March...

Viveve Medical (VIVE) traded down 1% after hours on estimating Q4 revenue at $1.9M vs. $1.5M in year ago quarter; global sales of disposable treatment tips increased 48% Y/Y.As of Dec. 31, 2020, the company had an installed base of 857 Viveve Systems worldwide.Total operat...

Q4 revenue growth, reduced operating expenses, and successful closing of public offering in January position Company with capital resources through end of 2022 Company to host a year-end conference call on March 18, 2021 at 5:00 PM ET ENGLEWOOD, CO / ACCESSWIRE / February 18, 2021...

Colorado Women on Boards Coalition names Viveve as top Colorado public company ENGLEWOOD, CO / ACCESSWIRE / February 9, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Colorado Women on Boards Coalition...

ENGLEWOOD, CO / ACCESSWIRE / February 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Korean Intellectual Property Office (KIPO) recently issued Korean Patent No. 10-2197234 titled, Vaginal Remodeling Dev...

Siebert Financial (SIEB) +453%.LM Funding America (LMFA) +101%.GameStop (GME) +75%.Koss Corporation (KOSS) +63%.Novavax (NVAX) +60% as its COVID-19 vaccine shows 89% efficacy in UK, 60% in South Africa.Catabasis Pharmaceuticals (CATB) +51% after announcing acquisition of Quellis Bio...

Healthcare Technology Report award recognizes outstanding contributions by SVP Suzon Lommel to advance innovative technologies that can transform patient outcomes ENGLEWOOD, CO / ACCESSWIRE / January 28, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on ...

Nano-cap Viveve Medical ([[VIVE]] +1.9%) has initiated its pivotal PURSUIT Trial to evaluate cryogen-cooled monopolar radiofrequency ((CMRF)) in stress urinary incontinence. The protocol of trial reflects changes to the study design approved by the FDA, including an increa...

New study design is more highly powered with improved patient selection criteria to better assess the primary efficacy endpoint Positive results could support a marketing application for new U.S. stress urinary incontinence indication ENGLEWOOD, CO / ACCESSWIRE / January 21, 2021...